TKP

TKP 511-2013
TKP 511-2013
Production of medications. Steam sterilization processes
TKP 511-2013 (02041)
TKP 511-2013 (02041)
Production of medicines. Steam Sterilization Processes
TKP 512-2013
TKP 512-2013
Production of medications. Medications based on recombinant DNA technology
TKP 512-2013 (02041)
TKP 512-2013 (02041)
Production of medicines. Recombinant DNA Technology Medicines
TKP 513-2013
TKP 513-2013
Production of medications. Studies for comparable biological drugs after a change in process of their production
TKP 513-2013 (02041)
TKP 513-2013 (02041)
Production of medicines. Comparability studies of biological drugs after changes in their manufacturing process
TKP 514-2013
TKP 514-2013
Production of medications. Medications based on heterologous cells
TKP 514-2013 (02041)
TKP 514-2013 (02041)
Production of medicines. Xenogenic Cell Based Medicines
TKP 515-2013
TKP 515-2013
Production of medications. Viral safety of drugs produced by biotechnological means using human and animal cells
TKP 515-2013 (02041)
TKP 515-2013 (02041)
Production of medicines. Viral safety of drugs obtained by biotechnological method using cells of human and animal origin
TKP 516-2013
TKP 516-2013
Production of medications. Quality control of similar medicines containing active substance proteins produced by biotechnological method
TKP 516-2013 (02041)
TKP 516-2013 (02041)
Production of medicines. Quality control of similar drugs containing biotechnologically produced proteins as active substances
TKP 517-2013
TKP 517-2013
Production of medications. Cytokines
TKP 517-2013 (02041)
TKP 517-2013 (02041)
Production of medicines. Cytokines
TKP 518-2013
TKP 518-2013
Production of medications. Pre-clinical evaluation of the safety of drugs produced by biotechnological methods
TKP 518-2013 (02041)
TKP 518-2013 (02041)
Production of medicines. Preclinical safety assessment of drugs obtained by biotechnological methods
TKP 519-2013
TKP 519-2013
Production of medications. Immunoglobulins and immune serum of animals used for treatment of humans
TKP 519-2013 (02041)
TKP 519-2013 (02041)
Production of medicines. Immunoglobulins and animal immune sera used for humans
TKP 52.3.03-2013
TKP 52.3.03-2013
Valuation of Objects of Civil Rights. Evaluation of value of old gardens.
TKP 52.3.03-2013 (03150)
TKP 52.3.03-2013 (03150)
Assessment of the value of civil rights. Estimation of the cost of perennial plantings
TKP 520-2013
TKP 520-2013
Production of medications. Inspection and acceptance criteria for medicinal products and substances produced by biotechnological methods
TKP 520-2013 (02041)
TKP 520-2013 (02041)
Production of medicines. Control and eligibility criteria for drugs and substances obtained by biotechnological methods
TKP 521-2013
TKP 521-2013
Production of medications. Drug stability tests of means and substances produced by biotechnological methods
TKP 521-2013 (02041)
TKP 521-2013 (02041)
Production of medicines. Testing the stability of drugs and substances obtained by biotechnological methods
TKP 522-2013
TKP 522-2013
Production of medications. Cellular substrates
TKP 522-2013 (02041)
TKP 522-2013 (02041)
Production of medicines. Cell substrates
TKP 523-2013
TKP 523-2013
Production of medications. Dry sterilization processes
TKP 523-2013 (02041)
TKP 523-2013 (02041)
Production of medicines. Dry heat sterilization processes
TKP 524-2013
TKP 524-2013
Production of medications. Use or transgenic animals
TKP 524-2013 (02041)
TKP 524-2013 (02041)
Production of medicines. Use of transgenic animals

All Codes and Regulations

All Categories

Send us a message Expand Collapse

Leave your message in the form below, and we will write back by e-mail!